Liver cancer rate by age U.S. 2022| ��ƽ��

Rate of new liver cancer diagnoses in the U.S. as of 2022, by age (per 100,000 population)

Characteristic	Rate per 100,000 population
Less than 1 year	1.4
1-4 years	0.8
5-9 years	0.1
10-14 years	0.1
15-19 years	0.2
20-24 years	0.2
25-29 years	0.4
30-34 years	0.5
35-39 years	1
40-44 years	1.8
45-49 years	3.6
50-54 years	6.8
55-59 years	15.3
60-64 years	27.6
65-69 years	40.4
70-74 years	43
75-79 years	44.8
80-84 years	45.7
85 years and older	38.6

Download

Source

Show detailed source information?

Already a member?

Source

Release date

August 2025

More information

Region

United States

Survey time period

2022

Supplementary notes

Release date represents the date figures were accessed.

Citation formats

The rate of liver cancer diagnoses in the United States increases with age. As of 2022, those aged 80 to 84 years had the highest rates of liver cancer. Risk factors for liver cancer include smoking, drinking alcohol, being overweight or obese, and having diabetes.

Who is most likely to get liver cancer?

Liver cancer in the United States is much more common among men than women. In 2022, there were 12 new liver cancer diagnoses among men per 100,000 population, compared to just five new diagnoses per 100,000 women. Concerning race and ethnicity, non-Hispanic American Indians and Alaska Natives and Hispanics have the highest rates of new liver cancer diagnoses. The five-year survival rate for liver cancer in the United States is around 22 percent; however, this rate is much higher among non-Hispanic Asian and Pacific Islanders than other races and ethnicities. Non-Hispanic Asian and Pacific Islanders have a 33 percent chance of surviving the next five years after a liver cancer diagnosis.

Deaths from liver cancer

In 2023, there were an estimated 29,911 deaths in the United States due to liver cancer. However, the death rate for liver cancer has remained stable over the past few years. In 2023, the death rate for liver cancer was 6.6 deaths per 100,000 population. It is estimated that in 2025, there will be over 19,000 liver and intrahepatic bile duct cancer deaths among men in the United States and 10,800 such deaths among women.